Comparative profiling and comprehensive quantification of stratum corneum ceramides in humans and mice by LC/MS/MS
Open accessAbstract
Ceramides are the predominant lipids in the stratum corneum (SC) and are crucial components for normal skin barrier function. Although the composition of various ceramide classes in the human SC has been reported, that in mice is still unknown, despite mice being widely used as animal models of skin barrier function. Here, we performed LC/MS/MS analyses using recently available ceramide class standards to measure 25 classes of free ceramides and 5 classes of protein-bound ceramides from human and mouse SC. Phytosphingosine- and 6-hydroxy sphingosine-type ceramides, which both contain an additional hydroxyl group, were abundant in the human SC (35% and 45% of total ceramides, respectively). In contrast, in mice, phytosphingosine- and 6-hydroxy sphingosine-type ceramides were present at ∼1% and undetectable levels, respectively, and sphingosine-type ceramides accounted for ∼90%. In humans, ceramides containing α-hydroxy FA were abundant, whereas ceramides containing β-hydroxy or ω-hydroxy FA were abundant in mice. The hydroxylated β-carbon in β-hydroxy ceramides was in the ( R ) configuration. Genetic knockout of β-hydroxy acyl-CoA dehydratases in HAP1 cells increased β-hydroxy ceramide levels, suggesting that β-hydroxy acyl-CoA, an FA-elongation cycle intermediate in the ER, is a substrate for β-hydroxy ceramide synthesis. We anticipate that our methods and findings will help to elucidate the role of each ceramide class in skin barrier formation and in the pathogenesis of skin disorders.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper establishes an LC/MS/MS method using deuterated standards to quantify free and protein-bound ceramides in human and mouse stratum corneum, revealing large class and species differences. Humans are rich in phytosphingosine- and 6-hydroxy sphingosine-type ceramides and α-hydroxy ceramides, whereas mice are dominated by sphingosine-type ceramides and contain more β-/ω-hydroxy and EO ceramides.
Key findings
- The method quantified 21 free ceramide classes/345 species in human SC and 16 classes/268 species in mouse SC; P-O ceramides were quantified as 5 classes/63 species in humans and 5 classes/74 species in mice.
- In human SC, NP, NH, and AH were abundant (24.2%, 23.7%, and 18.0% of total ceramides, respectively); 6-hydroxy sphingosine- and phytosphingosine-type ceramides accounted for 45.4% and 34.7%. In mouse SC, NS was highest (57.9%), sphingosine-type ceramides accounted for 87.7%, phytosphingosine-type ceramides were 1.2%, and 6-hydroxy sphingosine-type ceramides were undetectable.
- By FA type, human SC was 59.4% nonhydroxy, 32.5% α-hydroxy, 6.3% EO, 1.6% ω-hydroxy, and 0.17% β-hydroxy ceramides; mouse SC was 68.9% nonhydroxy, 16.9% EO, 8.7% ω-hydroxy, 4.9% β-hydroxy, and 0.7% α-hydroxy ceramides.
- The hydroxylated β-carbon in BS was in the (R) configuration, and HACD1/HACD2 double KO HAP1 cells showed a 15-fold increase in BS, suggesting β-hydroxy acyl-CoA from the ER FA elongation cycle is a substrate for BS synthesis.
Methods
- Human SC was collected by tape stripping from healthy volunteers (10 males and 9 females aged 20–50 y; n = 19); mouse SC was collected from the back of C57BL/6J mice on the first day after birth (n = 3), using the second tape strip for lipid extraction.
- Ceramides were analyzed by UPLC coupled to ESI tandem quadrupole MS in MRM mode with a reverse-phase C18 column and deuterium-labeled ceramide standards; matrix effects from tape extracts were tested, and P-O ceramides were released by KOH/methanol extraction.
- In vitro assays used HEK293T cells overexpressing CERS1 or CERS5 for BS synthesis and HACD1/HACD2 double KO HAP1 cells to test BS levels.
Limitations
- The paper states that it focused on and quantified ceramide species containing C18 chain-length LCBs, while LCBs with different chain lengths (C14–C26) reportedly exist in the epidermis and remain for future analysis.
- The paper states that further analyses are required for BS synthesis because (R)-β-hydroxy acyl-CoAs are also produced in peroxisomal β-oxidation and BS could alternatively be generated by β-hydroxylation of NS by an unidentified hydroxylase.
- The paper notes that mice deficient in a hydroxylase gene involved in hydroxylated ceramide production may not always be appropriate models for human skin disorders; evident from the text, the mouse sample was small (n = 3), from a single early time point and back skin, and no functional barrier measurements are reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
25 of 39 cited sources checked · 10 supported · 3 flagged · accuracy not yet measured
- Premisecitation
The fragment ion pattern of ceramides differs depending on their long-chain base moiety.
“Additionally, the fragment ion pattern of ceramides differs depending on their LCB moiety (5).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [5] Masukawa, 2008, Characterization of overall ceramide species in human stratum corneum, J. Lipid Res. source
- Premisecitation
The composition of ceramide classes/species in the human stratum corneum has previously been analyzed using LC/MS.
“The composition of ceramide classes/species in the human SC has previously been analyzed using LC/MS (5-7, 16, 17, 29, 30).”
Quote in the paperSubstantial claim3 of 7 sources checked- cites [5] Masukawa, 2008, Characterization of overall ceramide species in human stratum corneum, J. Lipid Res. source
- cites [6] van Smeden, 2011, LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery, J. Lipid Res. source
- cites [7] t'Kindt, 2012, Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry, Anal. Chem. source
- cites [16] Ishikawa, 2010, Changes in the ceramide profile of atopic dermatitis patients, J. Invest. Dermatol. source
- cites [17] Janssens, 2012, Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients, J. Lipid Res. source
- cites [29] Farwanah, 2005, Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS, Anal. Bioanal. Chem. source
- cites [30] Weerheim, 2001, Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography, Arch. Dermatol. Res. source
- Premisecitation
The fragmentation pattern of the peak at 12.86 min is consistent with that of C26:0 BS in previous reports.
“The fragmentation pattern of this peak is consistent with that of C26:0 BS in previous reports (12,42), demonstrating that the peak detected at 12.86 min was C26:0 BS.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [12] Tsugawa, 2017, Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library, J. Cheminform. source
- cites [42] Hsu, 2016, Complete structural characterization of ceramides as [M-H]– ions by multiple-stage linear ion trap mass spectrometry, Biochimie. source
- Premisecitation
More than several hundred ceramide species exist in the human stratum corneum.
“Therefore, more than several hundred ceramide species exist in the human SC (5)(6)(7).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [5] Masukawa, 2008, Characterization of overall ceramide species in human stratum corneum, J. Lipid Res. source
- cites [6] van Smeden, 2011, LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery, J. Lipid Res. source
The Abstract reports 11 identified ceramide subclasses in human stratum corneum, and the Results and Discussion describe variation in their chain lengths. These passages support the existence of many distinct ceramides, but our copy does not establish that the number of species exceeds several hundred. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [7] t'Kindt, 2012, Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry, Anal. Chem. source
- Interpretationcitation
The peak detected at 12.86 min in mouse epidermis was C26:0 BS.
“The fragmentation pattern of this peak is consistent with that of C26:0 BS in previous reports (12,42), demonstrating that the peak detected at 12.86 min was C26:0 BS.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [12] Tsugawa, 2017, Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library, J. Cheminform. source
The Results and discussion section, under “Annotation of β-hydroxy ceramide,” identifies an experimental MS/MS spectrum as Ceramide [BS] (d18:1/26:0) and reports Ceramide [BS] in murine ear tissue. It does not identify a peak at 12.86 min or report that measurement in mouse epidermis, so those specifics are not supported by this source. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [42] Hsu, 2016, Complete structural characterization of ceramides as [M-H]– ions by multiple-stage linear ion trap mass spectrometry, Biochimie. source
- Premisecitation
During ionization, dehydration of ceramide is often induced by in-source decay.
“Third, during ionization, the dehydration of ceramide is often induced by in-source decay (31).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [31] Rabionet, 2013, 1-O-acylceramides are natural components of human and mouse epidermis, J. Lipid Res. source
The Materials section reports significant in-source decay of 1-O-acylceramides leading to water loss during mass spectrometry. That supports the mechanism for this ceramide subtype, but not the broader claim that ceramides generally often undergo it. Page numbers were unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
In human skin transcriptome analysis, FPKM values of DEGS1 and DEGS2 were 186 and 32 (17% of DEGS1), respectively.
“In transcriptome analysis of human skin, the fragments per kilobase of transcript per million mapped reads (FPKM) values, which indicate relative gene expression levels, of DEGS1 and DEGS2 were 186 and 32 (17% of DEGS1), respectively (51).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [51] Skaug, 2020, Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile, Ann. Rheum. Dis. source
The Methods sections on skin biopsy and assignment to intrinsic subsets describe skin RNA sequencing and the use of FPKM values. Neither those passages nor the Results passage on transcript expression gives FPKM values for DEGS1 or DEGS2; searches for the gene names and the reported numbers found no matching passage in our copy. (LLM, conf=0.72)
Experimental — accuracy not yet measured
- Findingown data
Compared with standards diluted only with methanol, the detection ratio of each d9 ceramide mixed with tape extracts was decreased, especially in extracts from 200 and 400 mm2 pieces of tape.
“Compared with the standards diluted only with methanol (external standards), the detection ratio of each d 9 ceramide mixed with tape extracts was decreased, especially in the extracts from 200 and 400 mm 2 pieces of tape (Fig. 2G).”
Quote in the paperSubstantial claim - Findingown data
In mouse stratum corneum, ω-hydroxy ceramides were present at 8.7% of total ceramides.
“In humans, ceramides containing -hydroxy FA were abundant, whereas ceramides containing -hydroxy or -hydroxy FA were abundant in mice.”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“In mice, the EO, -hydroxy, and -hydroxy ceramide classes were 16.9%, 8.7%, and 4.9%, respectively, and -hydroxy ceramide, the second highest ceramide class in humans, was quite low (0.7%).”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingown data
In mouse stratum corneum, β-hydroxy ceramides were present at 4.9% of total ceramides.
“In humans, ceramides containing -hydroxy FA were abundant, whereas ceramides containing -hydroxy or -hydroxy FA were abundant in mice.”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“In mice, the EO, -hydroxy, and -hydroxy ceramide classes were 16.9%, 8.7%, and 4.9%, respectively, and -hydroxy ceramide, the second highest ceramide class in humans, was quite low (0.7%).”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingown data
In mouse stratum corneum, 6-hydroxy sphingosine-type ceramides were undetectable.
“In contrast, in mice, phytosphingosine-and 6-hydroxy sphingosine-type ceramides were present at 1% and undetectable levels, respectively, and sphingosine-type ceramides accounted for 90%.”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“The proportion of the phytosphingosine-type ceramide class in mice was low (1.2%), and the 6-hydroxy sphingosine-type ceramide class undetectable, in mice.”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingown data
In human stratum corneum, phytosphingosine-type ceramides were abundant, at 34.7% of total ceramides.
“Phytosphingosine-and 6-hydroxy sphingosine-type ceramides, which both contain an additional hydroxyl group, were abundant in the human SC (35% and 45% of total ceramides, respectively).”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“6-hydroxy sphingosine-and phytosphingosine-type ceramides were abundant in the human SC (45.4% and 34.7% of total ceramides, respectively) (Fig. 3C).”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingown data
The dissociation of NP yielded three major product ions (m/z 264, 282, and 300) at similar intensities.
“The dissociation of NP yielded three major product ions (m/z 264, 282, and 300) at similar intensities, of which two product ions (m/z 264 and 282) overlapped with the major and minor product ions of NS, respectively, indicating that the product ion of m/z 300 was specific to phytosphingosine-type ceramide.”
Quote in the paperSubstantial claim - Findingown data
The nondehydrated EOS and BS levels were about half of the dehydrated levels.
“The nondehydrated EOS and BS levels were about half of the dehydrated levels.”
Quote in the paperSubstantial claim - Findingown data
Genetic knockout of β-hydroxy acyl-CoA dehydratases in HAP1 cells increased β-hydroxy ceramide levels.
“Genetic knockout of -hydroxy acyl-CoA dehydratases in HAP1 cells increased -hydroxy ceramide levels, suggesting that -hydroxy acyl-CoA, an FA-elongation cycle intermediate in the ER, is a substrate for -hydroxy ceramide synthesis.”
Quote in the paperSubstantial claim - Findingown data
NSD was predominantly cleaved to a fragment ion of m/z 262, which corresponded to the SD moiety.
“NSD was predominantly cleaved to a fragment ion of m/z 262, which corresponded to the SD moiety (Fig. 2B).”
Quote in the paperSubstantial claim - Findingnone given
The hydroxylated β-carbon in β-hydroxy ceramides was in the (R) configuration.
“The hydroxylated -carbon in -hydroxy ceramides was in the (R) configuration.”
Quote in the paperNot a substantial claim - Findingown data
In mouse stratum corneum, sphingosine-type ceramides accounted for about 90% of total ceramides.
“In contrast, in mice, phytosphingosine-and 6-hydroxy sphingosine-type ceramides were present at 1% and undetectable levels, respectively, and sphingosine-type ceramides accounted for 90%.”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“On the other hand, the proportion of the sphingosine-type ceramide class was highest in the mouse SC (87.7%).”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingnone given
Ceramide species having different fatty acid moieties are separated by differences in m/z of their precursor ions and their retention time in LC.
“In addition, ceramide species having different FA moieties are separated by the differences in m/z of their precursor ions and their retention time in the LC.”
Quote in the paperSubstantial claim - Findingown data
In mouse stratum corneum, phytosphingosine-type ceramides were present at about 1% of total ceramides.
“In contrast, in mice, phytosphingosine-and 6-hydroxy sphingosine-type ceramides were present at 1% and undetectable levels, respectively, and sphingosine-type ceramides accounted for 90%.”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“The proportion of the phytosphingosine-type ceramide class in mice was low (1.2%), and the 6-hydroxy sphingosine-type ceramide class undetectable, in mice.”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingown data
In human stratum corneum, α-hydroxy ceramides were abundant, at 32.5% of total ceramides.
“In humans, ceramides containing -hydroxy FA were abundant, whereas ceramides containing -hydroxy or -hydroxy FA were abundant in mice.”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“followed by -hydroxy ceramides (32.5%),”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingnone given
Ceramide classes containing sphingosine, 6-hydroxy sphingosine, phytosphingosine, DS, and SD are distinguished in MRM analyses by selecting product ions of m/z 264, 280, 300, 284, and 262, respectively.
“In summary, the ceramide classes containing sphingosine, 6-hydroxy sphingosine, phytosphingosine, DS, and SD are distinguished in MRM analyses by selecting product ions of m/z 264, 280, 300, 284, and 262, respectively.”
Quote in the paperSubstantial claim - Findingown data
By fragmentation of NS and NH, product ions of m/z 264 and 280, corresponding to sphingosine and 6-hydroxy sphingosine moieties, respectively, were predominantly generated.
“By fragmentation of NS and NH, product ions of m/z 264 and 280, which correspond to sphingosine and 6-hydroxy sphingosine moieties, respectively, were predominantly generated (Fig. 2A).”
Quote in the paperSubstantial claim - Findingown data
In human stratum corneum, 6-hydroxy sphingosine-type ceramides were abundant, at 45.4% of total ceramides.
“Phytosphingosine-and 6-hydroxy sphingosine-type ceramides, which both contain an additional hydroxyl group, were abundant in the human SC (35% and 45% of total ceramides, respectively).”
- Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
“6-hydroxy sphingosine-and phytosphingosine-type ceramides were abundant in the human SC (45.4% and 34.7% of total ceramides, respectively) (Fig. 3C).”
Quote in the paperSubstantial claim - Also stated in: § Different SC ceramide classes and FA composition between humans and mice · plain
- Findingown data
In mouse stratum corneum, α-hydroxy ceramides were 0.7% of total ceramides.
“In mice, the EO, -hydroxy, and -hydroxy ceramide classes were 16.9%, 8.7%, and 4.9%, respectively, and -hydroxy ceramide, the second highest ceramide class in humans, was quite low (0.7%).”
Quote in the paperSubstantial claim - Findingown data
We determined the amounts of SD-type ceramides and BS for the first time.
“Although the amounts of SDtype ceramides and BS were previously unknown, we determined them for the first time (Fig. 3; supplemental Tables S2, S3).”
Quote in the paperSubstantial claim- Rests on an assumption: The amounts of SD-type ceramides and BS were previously unknown.
- Findingown data
In humans, C25:0 AH, C25:0 AP, and C31:0 EO ceramides (EOS, EOH, and EOP) were the third highest ceramide species in each ceramide class.
“In particular, the levels of C25:0 AH, C25:0 AP, and C31:0 EO ceramides (EOS, EOH, and EOP) in humans were the third highest ceramide species in each ceramide class.”
Quote in the paperNot a substantial claim - Findingown data
In mouse stratum corneum, nonhydroxy ceramides were 68.9% of total ceramides.
“Although nonhydroxy ceramide was the principal ceramide class present in both the mouse (68.9%) and human (59.4%)SC, the proportions of the other ceramide classes were largely different between mice and humans.”
Quote in the paperSubstantial claim - Findingown data
In human stratum corneum, nonhydroxy ceramides were 59.4% of total ceramides.
“Of the categories of ceramide classes that have the same type of FA, the proportion of the nonhydroxy ceramide class was the highest (59.4%) in the human SC, followed by -hydroxy ceramides (32.5%),EO ceramides (6.3%), and -hydroxy ceramides (1.6%) (Fig. 3D).”
Quote in the paperSubstantial claim - Findingown data
There are no remarkable differences in the FA chain length of ceramides between human and mouse SC.
“Overall, there were no remarkable differences in the FA chain length of ceramides between human and mouse SC.”
Quote in the paperSubstantial claim - Findingown data
In human stratum corneum, NP was 24.2% of total ceramides.
“In the human SC, NP, NH, and AH were abundant (24.2%, 23.7%, and 18.0% of total ceramides, respectively), followed by AP, NDS, NS, AS, EOH, EOS, EOP, and ADS (in descending order, 1% to 9%).”
Quote in the paperSubstantial claim - Findingown data
In human and mouse ceramide classes, the total percentage of ceramides with odd-chain FAs is 14% to 25% in humans and 6% to 10% in mice.
“The total percentage of ceramides with odd-chain FAs were 14% to 25% in human and 6% to 10% in mouse ceramide classes (Fig. 3F).”
Quote in the paperSubstantial claim - Findingown data
In human stratum corneum, NH was 23.7% of total ceramides.
“In the human SC, NP, NH, and AH were abundant (24.2%, 23.7%, and 18.0% of total ceramides, respectively), followed by AP, NDS, NS, AS, EOH, EOS, EOP, and ADS (in descending order, 1% to 9%).”
Quote in the paperNot a substantial claim - Findingown data
In human stratum corneum, AH was 18.0% of total ceramides.
“In the human SC, NP, NH, and AH were abundant (24.2%, 23.7%, and 18.0% of total ceramides, respectively), followed by AP, NDS, NS, AS, EOH, EOS, EOP, and ADS (in descending order, 1% to 9%).”
Quote in the paperNot a substantial claim - Findingown data
There are no clear differences in FA composition among P-O ceramide classes with different LCBs, both in humans and mice.
“There were no clear differences in FA composition among P-O ceramide classes with different LCBs, both in humans and mice (supplemental Table S5).”
Quote in the paperNot a substantial claim - Findingown data
In human stratum corneum, EO ceramides were 6.3% of total ceramides.
“Of the categories of ceramide classes that have the same type of FA, the proportion of the nonhydroxy ceramide class was the highest (59.4%) in the human SC, followed by -hydroxy ceramides (32.5%),EO ceramides (6.3%), and -hydroxy ceramides (1.6%) (Fig. 3D).”
Quote in the paperNot a substantial claim - Findingown data
In mice, P-OS is the most abundant P-O ceramide class at 84%.
“In mice, P-OS was also the most abundant (84%) P-O ceramide class.”
Quote in the paperNot a substantial claim - Findingown data
Human EO ceramides (EOS, EOH, and EOP) were composed of C30:0 > C32:0 > C31:0.
“Human EO ceramides (EOS, EOH, and EOP) were composed of C30:0 > C32:0 > C31:0.”
Quote in the paperNot a substantial claim - Findingown data
In the LC chromatogram of (R,S) C14:0 BS, two peaks (6.88 and 7.04 min) were detected.
“In the LC chromatogram of (R, S) C14:0 BS, two peaks (6.88 and 7.04 min) were again detected (Fig. 5B).”
Quote in the paperSubstantial claim - Findingown data
The composition of ceramide classes, especially in hydroxylated ceramide classes, is different between human and mouse SC.
“In this study, we revealed that the composition of ceramide classes, especially in hydroxylated ceramide classes, are different between human and mouse SC.”
Quote in the paperSubstantial claim - Findingown data
We successfully quantified 21 classes of ceramides from human stratum corneum, including 345 species.
“We successfully quantified 21 classes of ceramides from the human SC (NS, NDS, NH, NP, NSD, AS, ADS, AH, AP, ASD, BS, OS, ODS, OH, OP, OSD, EOS, EODS, EOH, EOP, and EOSD), including 345 species;”
Quote in the paperSubstantial claim - Findingown data
A variety of ceramide species, including phytosphingosine- and 6-hydroxy sphingosine-type ceramides, existed abundantly in the human SC.
“A variety of ceramide species, including phytosphingosine-and 6-hydroxy sphingosine-type ceramides, existed abundantly in the human SC.”
Quote in the paperSubstantial claim - Findingown data
The extracts from 25 and 50 mm2 pieces of tape did not affect the detection ratio.
“The extracts from 25 and 50 mm 2 pieces of tape did not affect the detection ratio.”
Quote in the paperSubstantial claim - Findingown data
SD-type ceramide levels were quite low, about 0.4%, both in humans and mice.
“SD-type ceramide levels were quite low (0.4%) both in humans and mice.”
Quote in the paperNot a substantial claim - Findingown data
In human stratum corneum, the proportions of other ceramide classes were lower than 1%.
“The proportions of other ceramide classes were lower than 1%.”
Quote in the paperNot a substantial claim - Findingown data
We successfully quantified 16 classes of ceramides from mouse stratum corneum, including 268 species.
“and 16 classes from the mouse SC (NS, NDS, NP, NSD, AS, ADS, ASD, BS, OS, ODS, OP, OSD, EOS, EODS, EOP, and EOSD), including 268 species (Fig. 3A, B; supplemental Table S2).”
Quote in the paperSubstantial claim - Findingown data
In human stratum corneum, ω-hydroxy ceramides were 1.6% of total ceramides.
“Of the categories of ceramide classes that have the same type of FA, the proportion of the nonhydroxy ceramide class was the highest (59.4%) in the human SC, followed by -hydroxy ceramides (32.5%),EO ceramides (6.3%), and -hydroxy ceramides (1.6%) (Fig. 3D).”
Quote in the paperNot a substantial claim - Findingown data
In human stratum corneum, trace amounts of β-hydroxy ceramides were present at 0.17% of total ceramides.
“Trace amounts of -hydroxy ceramides were present in the human SC (0.17%).”
Quote in the paperNot a substantial claim - Findingown data
In mouse stratum corneum, the proportions of other ceramide classes were lower than 2%.
“The proportions of other ceramide classes were lower than 2%.”
Quote in the paperNot a substantial claim - Findingown data
In human stratum corneum, AP, NDS, NS, AS, EOH, EOS, EOP, and ADS were present at 1% to 9% in descending order.
“In the human SC, NP, NH, and AH were abundant (24.2%, 23.7%, and 18.0% of total ceramides, respectively), followed by AP, NDS, NS, AS, EOH, EOS, EOP, and ADS (in descending order, 1% to 9%).”
Quote in the paperNot a substantial claim - Findingown data
Ceramides containing odd-chain fatty acids such as C25, C27, C29, and C31 were present at relatively high levels both in human and mouse stratum corneum.
“Although the levels of ceramides containing odd-chain FAs are generally low in a broad range of tissues, those containing oddchain FAs such as C25, C27, C29, and C31 were present at relatively high levels both in human and mouse SC.”
Quote in the paperSubstantial claim - Findingown data
In human SC, amounts of EO ceramides were comparable between EOS, EOH, and EOP.
“The amounts of EO ceramides were comparable between EOS, EOH, and EOP in the human SC (Fig. 3A), whereas those of P-O ceramides were different: P-OS was the most abundant, and P-OH and P-OP were half and 1/10 of P-OS, respectively (Fig. 4A).”
Quote in the paperNot a substantial claim - Findingown data
In mouse stratum corneum, EOS, NDS, OS, and BS followed NS in that order at 4% to 16% of total ceramides.
“In the mouse SC, NS levels were the highest (57.9% of total ceramides), followed by EOS, NDS, OS, and BS in that order (4% to 16%).”
Quote in the paperNot a substantial claim - Findingown data
In mouse stratum corneum, NS levels were the highest, at 57.9% of total ceramides.
“In the mouse SC, NS levels were the highest (57.9% of total ceramides), followed by EOS, NDS, OS, and BS in that order (4% to 16%).”
Quote in the paperSubstantial claim - Interpretationreasoning
β-hydroxy acyl-CoA, an FA-elongation cycle intermediate in the ER, is a substrate for β-hydroxy ceramide synthesis.
“Genetic knockout of -hydroxy acyl-CoA dehydratases in HAP1 cells increased -hydroxy ceramide levels, suggesting that -hydroxy acyl-CoA, an FA-elongation cycle intermediate in the ER, is a substrate for -hydroxy ceramide synthesis.”
Quote in the paperNot a substantial claim - Interpretationown data
The product ion of m/z 300 was specific to phytosphingosine-type ceramide.
“The dissociation of NP yielded three major product ions (m/z 264, 282, and 300) at similar intensities, of which two product ions (m/z 264 and 282) overlapped with the major and minor product ions of NS, respectively, indicating that the product ion of m/z 300 was specific to phytosphingosine-type ceramide.”
Quote in the paperSubstantial claim - Premisecitation
In mouse skin, FPKM values of Degs1 and Degs2 were 95 and 0.036 (0.04% of Degs1), respectively.
“On the other hand, the FPKM values of Degs1 and Degs2 were 95 and 0.036 (0.04% of Degs1) in the skin of mice (52).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Oberbeck, 2019, The RIPK4–IRF6 signalling axis safeguards epidermal differentiation and barrier function, Nature. source
- Interpretationreasoning
The difference in phytosphingosine-type ceramide levels between humans and mice may be due to the difference of expression levels of DEGS2.
“The difference in phytosphingosine-type ceramide levels between humans and mice may be due to the difference of expression levels of DEGS2.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Mice deficient in a hydroxylase gene involved in the production of hydroxylated ceramide may not always be appropriate as a model for human skin disorders.
“Therefore, it is predicted that the use of mice deficient in a hydroxylase gene involved in the production of hydroxylated ceramide may not always be appropriate as a model for human skin disorders.”
Quote in the paperSubstantial claim - Interpretationown data
The composition of stratum corneum ceramide classes was largely different between humans and mice.
“Thus, the composition of SC ceramide classes was largely different between humans and mice.”
Quote in the paperSubstantial claim - Premisecitation
Corneocytes are covered by a lipid monolayer mainly composed of P-O ceramides.
“Unlike plasma membranes in general, which are constituted by a lipid bilayer, corneocytes are covered by a lipid monolayer mainly composed of P-O ceramides (20), which are presumed to link corneocytes to the lipid lamellae.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Candi, 2005, The cornified envelope: a model of cell death in the skin, Nat. Rev. Mol. Cell Biol. source
- Classified as probably not a substantial claim. 8
- May combine two claims. 26
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the human stratum corneum, 16 ceramide classes other than SD and β-hydroxy ceramides have been identified.
“In the human SC, 16 ceramide classes other than SD and -hydroxy ceramides have been identified (5)(6)(7).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [5] Masukawa, 2008, Characterization of overall ceramide species in human stratum corneum, J. Lipid Res. source
The Nomenclature section describes 12 ceramide classes, including classes not previously reported, rather than 16 excluding SD and β-hydroxy ceramides. The Discussion reports identifying species within 11 classes; our copy does not substantiate the claimed count of 16. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [6] van Smeden, 2011, LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery, J. Lipid Res. source
The Abstract reports 11 previously identified ceramide subclasses in human stratum corneum and identifies one additional subclass, CER [EOdS]. The Results and Discussion likewise describe 12 subclasses as the theoretical total, contrary to the attributed count of 16 even before the stated exclusions. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [7] t'Kindt, 2012, Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry, Anal. Chem. source
May combine two claims.
PremisecitationIn Fa2h KO mice, neither the skin phenotype nor reduced AS levels in skin were observed.
“In Fa2h KO mice, neither the skin phenotype nor reduced AS levels in skin were observed (53).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [53] Maier, 2011, Normal fur development and sebum production depends on fatty acid 2-hydroxylase expression in sebaceous glands, J. Biol. Chem. source
In “Delayed Fur Emergence and Cyclic Alopecia in FA2H-deficient Mice” (page unavailable), the paper reports delayed fur development and repeated hair loss in Fa2h knockout mice—a skin phenotype, contrary to the claim. Its lipid analysis also reports reduced hydroxylated glucosylceramides in total skin, although hydroxylated ceramides showed no obvious change. The copy does not identify these measurements as “AS levels.” (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA portion of EO ceramides are converted into protein-bound ω-hydroxy ceramides, which are connected to cross-linked proteins constituting the cornified envelope.
“A portion of EO ceramides are converted into protein-bound hydroxy (P-O) ceramides (Fig. 1B), which are connected to cross-linked proteins constituting the cornified envelope, a structure located beneath the surface of corneocytes (20)(21)(22).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [20] Candi, 2005, The cornified envelope: a model of cell death in the skin, Nat. Rev. Mol. Cell Biol. source
- cites [21] Elias, 2014, Formation and functions of the corneocyte lipid envelope (CLE), Biochim. Biophys. Acta. source
- cites [22] Akiyama, 2017, Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis, J. Dermatol. Sci. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEO ceramides are epidermis-specific ceramide classes.
“EO ceramides are epidermisspecific ceramide classes, and their characteristic EO structure is important for the formation and stabilization of lipid organization in the lipid lamellae (18,19).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [18] Bouwstra, 2002, Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1, J. Invest. Dermatol. source
The paper’s introductory discussion describes human ceramides 1 and 4 with the characteristic ester-linked structure as ceramides isolated from the stratum corneum. It does not establish that these classes are specific to the epidermis rather than also occurring elsewhere. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [19] Lundborg, 2018, Human skin barrier structure and function analyzed by cryo-EM and molecular dynamics simulation, J. Struct. Biol. source
Section 4.2 (page unavailable) identifies CER EOS as a component of the human stratum corneum lipid structure, and section 4.1 reports that adding it brings the model’s lamellar periodicity closer to the observed value. The copy does not establish that EO ceramide classes are specific to the epidermis, nor does it directly show that their EO structure stabilizes the lamellae. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe characteristic EO structure is important for the formation and stabilization of lipid organization in the lipid lamellae.
“EO ceramides are epidermisspecific ceramide classes, and their characteristic EO structure is important for the formation and stabilization of lipid organization in the lipid lamellae (18,19).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [18] Bouwstra, 2002, Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1, J. Invest. Dermatol. source
The Discussion (page unavailable) concludes that human ceramide 1 plays an important role in forming the long-periodicity lamellar phase and that its acyl-chain structure affects lamellar organization. This supports the formation part of the claim, but the paper does not establish that the EO structure stabilizes an existing lipid organization. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [19] Lundborg, 2018, Human skin barrier structure and function analyzed by cryo-EM and molecular dynamics simulation, J. Struct. Biol. source
In Results §3.1 (page not available), changing CER EOS content alters the modeled lipid lamellae’s periodicity, and a model containing 5% CER EOS best matches the cryo-EM images. Discussion §4.1 likewise says adding CER EOS helps reproduce the observed periodicity. These findings support a role in lamellar organization, but the paper does not establish that the characteristic EO structure is important for its formation or stabilization. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationIn that report, it is likely that BS, but not AS, was measured, because AS levels were determined by TLC or MS analysis without LC separation.
“In that report, however, it is likely that BS, but not AS, was measured, because AS levels were determined by TLC or MS analysis without LC separation (53).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [53] Maier, 2011, Normal fur development and sebum production depends on fatty acid 2-hydroxylase expression in sebaceous glands, J. Biol. Chem. source
The Experimental Procedures (page not available) describe TLC analysis and direct injection into the mass spectrometer, supporting the claim that no LC separation preceded MS. The paper groups shorter-chain hydroxylated sphingolipids as α-hydroxy based on chain length, but does not establish that the measured material was likely BS rather than AS. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEarlier studies have reported that ceramides with odd-chain FAs exist at high levels in the SC.
“Earlier studies have reported that ceramides with oddchain FAs exist at high levels in the SC (Fig. 3F, supplemental Table S3) (7,55).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [7] t'Kindt, 2012, Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry, Anal. Chem. source
- cites [55] Masukawa, 2009, Comprehensive quantification of ceramide species in human stratum corneum, J. Lipid Res. source
The Methods passage lists an odd-chain ceramide, CER[N(17)S(18)], as an internal standard, not as a ceramide found at high levels in stratum corneum. Searches for odd-chain fatty acids and their abundance found no passage in our copy reporting the claimed high levels; the paper discusses quantifying ceramide species generally. (LLM, conf=0.72)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationSphingosine- and phytosphingosine-type ceramides are generated either via desaturation between the 4 and 5 positions of the LCB moiety of dihydroceramides (DS ceramides) by DEGS1, or via hydroxylation of the same moiety at the 4 position by DEGS2.
“Sphingosine-and phytosphingosine-type ceramides are generated either via desaturation between the 4 and 5 positions of the LCB moiety of dihydroceramides (DS ceramides) by the desaturase DEGS1, or via hydroxylation of the same moiety at the 4 position by the hydroxylase DEGS2 (49,50).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [49] Omae, 2004, DES2 protein is responsible for phytoceramide biosynthesis in the mouse small intestine, Biochem. J. source
- cites [50] Ternes, 2002, Identification and characterization of a sphingolipid Δ4-desaturase family, J. Biol. Chem. source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLCBs with different chain lengths (C14-C26) reportedly exist in the epidermis.
“Although we focused on and quantified ceramide species containing LCBs with a C18 chain length, LCBs with different chain lengths (C14-C26) reportedly exist in the epidermis (57).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [57] Pons, 2002, Gas-chromatography/mass-spectrometry analysis of human skin constituents as heptafluorobutyrate derivatives with special reference to long-chain bases, J. Lipid Res. source
Table 2 (shown under “Conclusion and Perspectives”; page unavailable) identifies LCBs with multiple chain lengths, including C16 through C26, in a human skin extract. It does not identify a C14 LCB, and the analysis is of skin extracts rather than the epidermis specifically. The claimed C14–C26 range in the epidermis is therefore only partly supported. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataDehydrated AS was detected predominantly, whereas nondehydrated OS was detected at the same levels as dehydrated OS.
“Dehydrated AS was also detected predominantly, whereas nondehydrated OS was detected at the same levels as dehydrated OS.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn LC/MS/MS analysis using an MRM setting to detect C26:0 AS, C26:0 AS was detected in human stratum corneum at 13.20 min, while a large peak at 12.86 min was detected in mouse epidermis.
“In LC/MS/MS analysis using the MRM setting to detect C26:0 AS, C26:0 AS was detected in the human SC (13.20 min), while a large peak at an earlier retention time (12.86 min), instead of C26:0 AS, was detected in the mouse epidermis (Fig. 2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataProduct ions of m/z 266 and 284 were mainly produced by fragmentation of NDS, and neither were detected in other ceramide classes.
“Product ions of m/z 266 and 284 were mainly produced by the fragmentation of NDS, and neither were detected in other ceramide classes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCeramide classes with double bond(s) in their long-chain base (NS, NH, and NSD) were highly dehydrated, while those without double bonds (NDS and NP) were not.
“Ceramide classes with double bond(s) in their LCB (NS, NH, and NSD) were highly dehydrated, while those without double bonds (NDS and NP) were not (Fig. 2F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe fatty acid compositions of human AH, human AP, and mouse BS were C26:0 > C24:0 > C25:0; C24:0 > C26:0 > C25:0; and C26:0 > C28:0 > C25:0, respectively.
“The FA compositions of the human AH, AP, and mouse BS were C26:0 > C24:0 > C25:0; C24:0 > C26:0 > C25:0; and C26:0 > C28:0 > C25:0, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGenerally, the fatty acid chain length of ω-hydroxylated ceramides (EO and ω-hydroxy) was C30-C34, and that of other ceramides was C16-C30.
“Generally, the FA chain length of -hydroxylated ceramides (EO and -hydroxy) was C30-C34, and that of the other ceramides was C16-C30.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn human SC P-O ceramides, P-OS was the most abundant, and P-OH and P-OP were half and 1/10 of P-OS, respectively.
“The amounts of EO ceramides were comparable between EOS, EOH, and EOP in the human SC (Fig. 3A), whereas those of P-O ceramides were different: P-OS was the most abundant, and P-OH and P-OP were half and 1/10 of P-OS, respectively (Fig. 4A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataC26:0 and C24:0 were the top two fatty acids in most ceramide classes, other than ω-hydroxy or EO ceramides, although C16:0 was the principal fatty acid in human AS.
“C26:0 and C24:0 were the top two FAs in most ceramide classes, other than -hydroxy or EO ceramides, although C16:0 was the principal ceramide present in human AS (C16:0 > C26:0 > C24:0).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMajor fatty acids of nonhydroxy ceramides were C26:0 > C24:0 > C28:0 both in human and mouse stratum corneum, except for human NDS, which was C24:0 > C26:0 > C28:0.
“Major FAs of nonhydroxy ceramides were C26:0 > C24:0 > C28:0 both in human and mouse SC (except for human NDS, which was C24:0 > C26:0 > C28:0).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFA species constituting P-OS are C30-C34, with C30:0 > C32:0 > C32:1 in humans and C34:1 ≈ C32:0 > C32:1 in mice.
“FA species that constituted P-OS were C30-C34 (C30:0 > C32:0 > C32:1 in humans and C34:1 ≈ C32:0 > C32:1 in mice) (Fig. 4B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the LC chromatogram of synthesized (R,S) C18:0 BS, two peaks were observed at 8.63 and 8.78 min, and the latter peak was identical with C18:0 BS in mouse epidermis.
“In the LC chromatogram of the synthesized (R, S) C18:0 BS, two peaks were observed at 8.63 and 8.78 min, and the latter peak was identical with C18:0 BS in the mouse epidermis (Fig. 5A).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe ratio of each ceramide class to total ceramides in this study was not largely different from earlier studies.
“The ratio of each ceramide class to total ceramides in this study was not largely different from earlier studies (supplemental Table S6).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn mouse SC, 16 free ceramide classes/268 species and 5 P-O ceramide classes/74 species were quantified.
“In the current study, we performed LC/MS/MS analyses and quantified free ceramides (21 classes/345 species in humans; 16 classes/268 species in mice) and P-O ceramides (5 classes/63 species in humans; 5 classes/74 species in mice) (Figs. 3, 4; supplemental Tables S2-S5), revealing the in-depth ceramide profiles of human and mouse SC.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWe successfully quantified 63 P-O ceramide species in humans and 74 P-O ceramide species in mice.
“Although semiquantitative analysis of P-O ceramides by TLC and quantification of limited P-O ceramide species by LC/MS/MS have already been conducted (44-46), we successfully quantified 63 and 74 P-O ceramide species in humans and mice, respectively, leading to the elucidation of the detailed composition of P-O ceramides.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the LC chromatogram of (R) C14:0 BS, two peaks (6.79 and 6.96 min) were observed, and the latter peak was larger than the former.
“Although two peaks (6.79 and 6.96 min) were also observed in (R) C14:0 BS, the latter peak was larger than the former, indicating that the former and latter peaks corresponded to (S) BS and (R) BS, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn human SC, 21 free ceramide classes/345 species and 5 P-O ceramide classes/63 species were quantified.
“In the current study, we performed LC/MS/MS analyses and quantified free ceramides (21 classes/345 species in humans; 16 classes/268 species in mice) and P-O ceramides (5 classes/63 species in humans; 5 classes/74 species in mice) (Figs. 3, 4; supplemental Tables S2-S5), revealing the in-depth ceramide profiles of human and mouse SC.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn mouse SC, phytosphingosine-type ceramides were at very low levels and 6-hydroxy sphingosine-type ceramides were undetectable.
“On the other hand, phytosphingosine-and 6-hydroxy sphingosine-type ceramides were at very low and undetectable levels, respectively, in the mouse SC (Fig. 3; supplemental Tables S2, S3).”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationIn humans, P-OS is the predominant P-O ceramide class, comprising 64% of total P-O ceramides, followed by P-OH at 28%.
“Consistent with earlier reports (43,44), in humans, P-OS was predominant (64% of total P-O ceramides), followed by P-OH (28%) (Fig. 4A; supplemental Tables S4, S5).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Findingown dataMouse EOS and OS contained C32:0 > C30:0 > C34:1 and C32:0 > C34:1 > C30:0, respectively.
“Mouse EOS and OS contained C32:0 > C30:0 > C34:1 and C32:0 > C34:1 > C30:0, respectively.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCeramides account for approximately 50% by weight of the main constituents of lipid lamellae in the stratum corneum.
“The main constituents of lipid lamellae are ceramides, cholesterol, and FFAs, of which ceramides account for 50% by weight (4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Yardley, 1981, Lipid composition and metabolism in normal and diseased epidermis, Pharmacol. Ther. source
May combine two claims.
Interpretationown dataAlthough a matrix effect (suppression of ionization) is caused by tape-derived coextracts, this effect can be nullified by reducing the tape size to 50 mm2 or less.
“From this result, although a matrix effect (suppression of ionization) is caused by the tape-derived coextracts, this effect can be nullified by reducing the tape size to 50 mm 2 or less.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe difference in LCB composition between EO and P-O ceramides indicates that the conversion efficiency of EO to P-O ceramides varies depending on the LCB structure (the presence of hydroxylation), presumably due to low activities against EOP and EOH of enzymes involved in P-O ceramide production.
“Because P-O ceramides are derived from EO ceramides, the difference in LCB composition between EO and P-O ceramides indicates that the conversion efficiency of EO to P-O ceramides varies depending on the LCB structure (the presence of hydroxylation), presumably due to the low activities against EOP and EOH of the enzymes involved in the production of P-O ceramides.”
Quote in the paperSubstantial claim- Rests on an assumption: P-O ceramides are derived from EO ceramides.
May combine two claims.
InterpretationreasoningThe absence of 6-hydroxy sphingosine-type ceramide in mice suggests that the gene involved does not exist in mice or is not expressed in the skin of mice.
“Although the gene responsible for the production of 6-hydroxy sphingosine-type ceramide has not yet been identified, the absence of 6-hydroxy sphingosine-type ceramide in mice suggests that the gene involved does not exist in mice or is not expressed in the skin of mice.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe former and latter peaks in (R) C14:0 BS correspond to (S) BS and (R) BS, respectively.
“Although two peaks (6.79 and 6.96 min) were also observed in (R) C14:0 BS, the latter peak was larger than the former, indicating that the former and latter peaks corresponded to (S) BS and (R) BS, respectively.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The appropriate maintenance of the amount and composition of stratum corneum ceramides is important for normal skin barrier function.
“The appropriate maintenance of the amount and composition of SC ceramides is important for normal skin barrier function.”
The paper relies on this without support.
It is currently unclear whether 4E,14Z-sphingadiene is present in the epidermis.
“It is currently unclear whether SD is present in the epidermis.”
The paper relies on this without support.
The presence of β-hydroxy ceramides in human skin has not yet been determined.
“Although ceramides containing -hydroxy FA have recently been identified in the mouse epidermis (11,12), their presence in human skin has not yet been determined.”
The paper relies on this without support.
The degree of dehydration of each ceramide class has not yet been determined.
“However, the degree of dehydration of each ceramide class has not yet been determined.”
The paper relies on this without support.
The amounts of ceramide classes other than sphingosine-type ceramides in mice have not yet been elucidated.
“Thus, although mice have been generally utilized as a model animal for studying skin barrier function, the ceramide classes measured have primarily been sphingosine-type ceramides such as NS and EOS, and the amounts of other ceramide classes have not yet been elucidated.”
The paper relies on this without support.
The matrix effect caused by coextracted compounds from the tape is unknown.
“Although an SC sample is often collected by tape stripping, the matrix effect caused by coextracted compounds from the tape is unknown.”
The paper relies on this without support.
It is difficult to separately detect and precisely quantify a tremendous number of ceramide species by LC/MS.
“However, it is difficult to separately detect and precisely quantify such a tremendous number of ceramide species by LC/MS.”
The paper relies on this without support.
P-O ceramides are derived from EO ceramides.
“Because P-O ceramides are derived from EO ceramides, the difference in LCB composition between EO and P-O ceramides indicates that the conversion efficiency of EO to P-O ceramides varies depending on the LCB structure (the presence of hydroxylation), presumably due to the low activities against EOP and EOH of the enzymes involved in the production of P-O ceramides.”
The paper relies on this without support.
The amounts of SD-type ceramides and BS were previously unknown.
“Although the amounts of SDtype ceramides and BS were previously unknown, we determined them for the first time (Fig. 3; supplemental Tables S2, S3).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
NSD synthesis incubation time differs between Methods and Fig. 2
MinorThe Methods specify a 30-minute incubation for NSD synthesis, while the Fig. 2 caption specifies 1 hour for the same synthesis.
“For NSD synthesis, the membrane fraction (50 µg) prepared from the cells overexpressing CERS5 was mixed with 1 µM SD and 1 µM C16:0-CoA (Merck) (total volume: 50 µl) and incubated (37°C, 30 min).”
“C16:0 NSD was synthesized by incubating 1 µM SD and 1 µM C16:0-CoA with membrane fractions (50 µg) prepared from HEK 293T cells overexpressing CERS5 at 37°C for 1 h (B).”
Cites
The cornified envelope: a model of cell death in the skin
Candi, E., Schmidt, R., & Melino, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1619 · Cited by 1,776 · see citing works
Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G. T., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,309 · see citing works
Imokawa, G., Abe, A., Jin, K., Higaki, Y., Kawashima, M., & Hidano, A. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12470233 · Cited by 1,040 · see citing works
Janssens, M., van Smeden, J., Gooris, G. S., Bras, W., Portale, G., Caspers, P. J., Vreeken, R. J., Hankemeier, T., Kezic, S., Wolterbeek, R., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p030338 · Cited by 488 · see citing works
Very long-chain fatty acids: elongation, physiology and related disorders
Kihara, A. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs105 · Cited by 441 · see citing works
Self-citationPruett, S. T., Bushnev, A. S., Hagedorn, K., Adiga, M., Haynes, C. A., Sullards, M. C., Liotta, D. C., & Merrill, A. H. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800012-jlr200 · Cited by 436 · see citing works
Changes in the Ceramide Profile of Atopic Dermatitis Patients
Ishikawa, J., Narita, H., Kondo, N., Hotta, M., Takagi, Y., Masukawa, Y., Kitahara, T., Takema, Y., Koyano, S., Yamazaki, S., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.161 · Cited by 372 · see citing works
Characterization of overall ceramide species in human stratum corneum
Masukawa, Y., Narita, H., Shimizu, E., Kondo, N., Sugai, Y., Oba, T., Homma, R., Ishikawa, J., Takagi, Y., Kitahara, T., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800014-jlr200 · Cited by 322 · see citing works
Metabolism of Very Long-Chain Fatty Acids: Genes and Pathophysiology
Sassa, T., & Kihara, A. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.017 · Cited by 302 · see citing works
Self-citationWeerheim, A., & Ponec, M. (2001) · Archives of Dermatological Research · doi:10.1007/s004030100212 · Cited by 302 · see citing works
Identification and Characterization of a Sphingolipid Δ4-Desaturase Family
Ternes, P., Franke, S., Zähringer, U., Sperling, P., & Heinz, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202947200 · Cited by 293 · see citing works
Loss of ceramide synthase 3 causes lethal skin barrier disruption
Jennemann, R., Rabionet, M., Gorgas, K., Epstein, S., Dalpke, A. H., Rothermel, U., Bayerle, A., van der Hoeven, F., Imgrund, S., Kirsch, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr494 · Cited by 283 · see citing works
Lipid composition and metabolism in normal and diseased epidermis
Yardley, H. J., & Summerly, R. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90006-1 · Cited by 267 · see citing works
6-Hydroxy-4-sphingenine in human epidermal ceramides.
Robson, K. J., Stewart, M. E., Michelsen, S., Lazo, N. D., & Downing, D. T. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39952-1 · Cited by 263 · see citing works
Epithelial barrier repair and prevention of allergy
Goleva, E., Berdyshev, E., & Leung, D. Y. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124608 · Cited by 251 · see citing works
Vasireddy, V., Uchida, Y., Salem, N., Kim, S. Y., Mandal, M. N. A., Reddy, G. B., Bodepudi, R., Alderson, N. L., Brown, J. C., Hama, H., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl480 · Cited by 247 · see citing works
Kihara, A. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.04.001 · Cited by 238 · see citing works
Self-citationLC/MS analysis of stratum corneum lipids: ceramide profiling and discovery
van Smeden, J., Hoppel, L., van der Heijden, R., Hankemeier, T., Vreeken, R. J., & Bouwstra, J. A. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014456 · Cited by 229 · see citing works
Comprehensive quantification of ceramide species in human stratum corneum
Masukawa, Y., Narita, H., Sato, H., Naoe, A., Kondo, N., Sugai, Y., Oba, T., Homma, R., Ishikawa, J., Takagi, Y., et al. (2009) · Journal of Lipid Research · doi:10.1194/jlr.d800055-jlr200 · Cited by 228 · see citing works
Covalently Bound Lipids of Human Stratum Corneum
Wertz, P. W., Madison, K. C., & Downing, D. T. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep13071317 · Cited by 205 · see citing works
Peroxisomes, lipid metabolism, and peroxisomal disorders
Wanders, R. J. A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.08.016 · Cited by 205 · see citing works
t’Kindt, R., Jorge, L., Dumont, E., Couturon, P., David, F., Sandra, P., & Sandra, K. (2012) · Analytical Chemistry · doi:10.1021/ac202646v · Cited by 202 · see citing works
Skaug, B., Khanna, D., Swindell, W. R., Hinchcliff, M. E., Frech, T. M., Steen, V. D., Hant, F. N., Gordon, J. K., Shah, A. A., Zhu, L., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215894 · Cited by 179 · see citing works
The role of sphingolipid metabolism in cutaneous permeabilitybarrier formation
Breiden, B., & Sandhoff, K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.010 · Cited by 176 · see citing works
Formation and functions of the corneocyte lipid envelope (CLE)
Elias, P. M., Gruber, R., Crumrine, D., Menon, G., Williams, M. L., Wakefield, J. S., Holleran, W. M., & Uchida, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.09.011 · Cited by 169 · see citing works
Sassa, T., Ohno, Y., Suzuki, S., Nomura, T., Nishioka, C., Kashiwagi, T., Hirayama, T., Akiyama, M., Taguchi, R., Shimizu, H., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00192-13 · Cited by 167 · see citing works
Self-citationBouwstra, J. A., Gooris, G. S., Dubbelaar, F. E. R., & Ponec, M. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01706.x · Cited by 165 · see citing works
PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis
Hirabayashi, T., tatsuki, A., Kaneko, A., Senoo, Y., Shibata, A., Takama, H., Yokoyama, K., Nishito, Y., Ono, T., Taya, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14609 · Cited by 135 · see citing works
Ikeda, M., Kanao, Y., Yamanaka, M., Sakuraba, H., Mizutani, Y., Igarashi, Y., & Kihara, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.007 · Cited by 132 · see citing works
Self-citationThe importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier
Muñoz‐Garcia, A., Thomas, C. P., Keeney, D. S., Zheng, Y., & BRASH, A. R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.020 · Cited by 123 · see citing works
PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide
Ohno, Y., Kamiyama, N., Nakamichi, S., & Kihara, A. (2017) · Nature Communications · doi:10.1038/ncomms14610 · Cited by 121 · see citing works
Self-citationDES2 protein is responsible for phytoceramide biosynthesis in the mouse small intestine
OMAE, F., MIYAZAKI, M., ENOMOTO, A., SUZUKI, M., SUZUKI, Y., & SUZUKI, A. (2004) · Biochemical Journal · doi:10.1042/bj20031425 · Cited by 118 · see citing works
Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis
Aioi, A., Tonogaito, H., Suto, H., et al. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.03946.x · Cited by 116 · see citing works
Akiyama, M. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.002 · Cited by 113 · see citing works
The role of epidermal sphingolipids in dermatologic diseases
Borodzicz-Jażdżyk, S., Rudnicka, L., Mirowska-Guzel, D. M., & Cudnoch‐Jędrzejewska, A. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0178-7 · Cited by 112 · see citing works
Nonsyndromic types of ichthyoses – an update
Traupe, H., Fischer, J., & Oji, V. (2013) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12229 · Cited by 111 · see citing works
Gray, G. M., White, R. J., & Majer, J. R. (1978) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(78)90058-9 · Cited by 97 · see citing works
Profiling of human stratum corneum ceramides by means of normal phase LC/APCI–MS
Farwanah, H., Wohlrab, J., Neubert, R. H. H., & Raith, K. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-0044-3 · Cited by 86 · see citing works
The RIPK4–IRF6 signalling axis safeguards epidermal differentiation and barrier function
Oberbeck, N., Pham, V. C., Webster, J. D., Reja, R., Huang, C. S., Zhang, Y., Roose-Girma, M., Warming, S., Li, Q., Birnberg, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1615-3 · Cited by 86 · see citing works
Tsugawa, H., Ikeda, K., Tanaka, W., Senoo, Y., Arita, M., & Arita, M. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0205-3 · Cited by 82 · see citing works
1-O-acylceramides are natural components of human and mouse epidermis
Rabionet, M., Bayerle, A., Marsching, C., Jennemann, R., Gröne, H.-J., Yildiz, Y., Wachten, D., Shaw, W., Shayman, J. A., & Sandhoff, R. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040097 · Cited by 81 · see citing works
Human skin barrier structure and function analyzed by cryo-EM and molecular dynamics simulation
Lundborg, M., Narangifard, A., Wennberg, C. L., Lindahl, E., Daneholt, B., & Norlén, L. (2018) · Journal of Structural Biology · doi:10.1016/j.jsb.2018.04.005 · Cited by 77 · see citing works
Kitamura, T., Seki, N., & Kihara, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700138114 · Cited by 73 · see citing works
Self-citationThe stratum corneum: the rampart of the mammalian body
Nishifuji, K., & Yoon, J. S. (2013) · Veterinary Dermatology · doi:10.1111/j.1365-3164.2012.01090.x · Cited by 69 · see citing works
Sawai, M., Uchida, Y., Ohno, Y., Miyamoto, M., Nishioka, C., Itohara, S., Sassa, T., & Kihara, A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.803171 · Cited by 69 · see citing works
Self-citationYamamoto, H., Hattori, M., Chamulitrat, W., Ohno, Y., & Kihara, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917525117 · Cited by 63 · see citing works
Self-citationPark, Y.-H., Jang, W.-H., Seo, J. A., Park, M., Lee, T. R., Park, Y.-H., Kim, D. K., & Lim, K. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.333 · Cited by 61 · see citing works
Jojima, K., Edagawa, M., Sawai, M., Ohno, Y., & Kihara, A. (2020) · The FASEB Journal · doi:10.1096/fj.201902645r · Cited by 51 · see citing works
Self-citationHsu, F.-F. (2016) · Biochimie · doi:10.1016/j.biochi.2016.07.012 · Cited by 48 · see citing works
Maier, H., Meixner, M., Hartmann, D., Sandhoff, R., Wang-Eckhardt, L., Zöller, I., Gieselmann, V., & Eckhardt, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231977 · Cited by 45 · see citing works
Miyamoto, M., Itoh, N., Sawai, M., Sassa, T., & Kihara, A. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.07.689 · Cited by 40 · see citing works
Self-citationLin, M., Hsu, F., Crumrine, D. A., Meyer, J. M., Elias, P. M., & Miner, J. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-49684-y · Cited by 32 · see citing works
Homeostatic Function of Dermokine in the Skin Barrier and Inflammation
Utsunomiya, A., Chino, T., Utsunomiya, N., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.09.011 · Cited by 25 · see citing works
Fujiwara, A., Morifuji, M., Kitade, M., Kawahata, K., Fukasawa, T., Yamaji, T., Itoh, H., & Kawashima, M. (2018) · Archives of Dermatological Research · doi:10.1007/s00403-018-1859-z · Cited by 24 · see citing works
Pons, A., Timmerman, P., Leroy, Y., & Zanetta, J.-P. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30122-x · Cited by 23 · see citing works
Linoleate content of epidermal acylglucosylceramide in newborn, growing and mature mice
Wertz, P. W., & Downing, D. T. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90033-0 · Cited by 20 · see citing works
Edagawa, M., Sawai, M., Ohno, Y., & Kihara, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.09.002 · Cited by 11 · see citing works
Self-citationThe Stratum Corneum: The Rampart of the Mammalian Body
Nishifuji, K., & Yoon, J. S. (2013) · Advances in Veterinary Dermatology · doi:10.1002/9781118644317.ch9 · Cited by 5 · see citing works
Tsugawa, H., Ikeda, K., Tanaka, W., et al. (2017) · Figshare · doi:10.6084/m9.figshare.4757602
Flagged first, then by citations
Cited by
Sorted by citations
Skin lipids in health and disease: A review
Knox, S. E., & O’Boyle, N. M. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105055 · Cited by 201 · see citing works
The skin barrier: An extraordinary interface with an exceptional lipid organization
Bouwstra, J. A., Nădăban, A., Bras, W., McCabe, C., Bunge, A. L., & Gooris, G. S. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101252 · Cited by 184 · see citing works
Ceramides in Skin Health and Disease: An Update
Uchida, Y., & Park, K. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00619-2 · Cited by 138 · see citing works
Protective Barriers Provided by the Epidermis
de Szalay, S., & Wertz, P. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043145 · Cited by 107 · see citing works
Suzuki, M., Ohno, Y., & Kihara, A. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100235 · Cited by 101 · see citing works
Self-citationBouwstra, J. A., Helder, R. W. J., & Ghalbzouri, A. E. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.012 · Cited by 94 · see citing works
The heterogeneity and complexity of skin surface lipids in human skin health and disease
Mijaljica, D., Townley, J. P., Spada, F., & Harrison, I. P. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101264 · Cited by 95 · see citing works
The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis
Fujii, M. (2021) · Cells · doi:10.3390/cells10092386 · Cited by 84 · see citing works
The stratum corneum barrier – From molecular scale to macroscopic properties
Sparr, E., Björklund, S., Pham, Q. D., Mojumdar, E. H., Stenqvist, B., Gunnarsson, M., & Topgaard, D. (2023) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2023.101725 · Cited by 65 · see citing works
Bioactive lipids in the skin barrier mediate its functionality in health and disease
Nicolaou, A., & Kendall, A. C. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108681 · Cited by 56 · see citing works
Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
Lunter, D. J., Klang, V., Eichner, A., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060817 · Cited by 53 · see citing works
Mechanisms of the Drug Penetration Enhancer Propylene Glycol Interacting with Skin Lipid Membranes
Mistry, J., & Notman, R. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c06784 · Cited by 51 · see citing works
Using molecular simulation to understand the skin barrier
Shamaprasad, P., Frame, C. O., Moore, T. C., Yang, A., Iacovella, C. R., Bouwstra, J. A., Bunge, A. L., & McCabe, C. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101184 · Cited by 46 · see citing works
Tyrrell, V. J., Ali, F., Boeglin, W. E., Andrews, R., Burston, J. J., Birchall, J. C., Ingram, J. R., Murphy, R. C., Piguet, V., BRASH, A. R., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100094 · Cited by 45 · see citing works
Zhang, Y., Liu, C., Xu, W., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120503 · Cited by 41 · see citing works
Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases
Kleuser, B., & Bäumer, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021456 · Cited by 40 · see citing works
Nădăban, A., Rousel, J., Yachioui, D. E., Gooris, G. S., Beddoes, C. M., Dalgliesh, R. M., Malfois, M., Rißmann, R., & Bouwstra, J. A. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100400 · Cited by 37 · see citing works
Kim, B., Shon, J. C., Seo, H. S., Liu, K., Lee, J. W., Ahn, S. K., & Hong, S. P. (2021) · Experimental Dermatology · doi:10.1111/exd.14431 · Cited by 36 · see citing works
Eckhardt, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054908 · Cited by 33 · see citing works
Schild, J., Kalvodová, A., Zbytovská, J., Farwick, M., & Pyko, C. (2024) · International Journal of Cosmetic Science · doi:10.1111/ics.12972 · Cited by 34 · see citing works
Ossowicz-Rupniewska, P. E., Nowak, A., Klebeko, J., Janus, E., Duchnik, W., Adamiak-Giera, U., Kucharski, Ł., Prowans, P., Petriczko, J., Czapla, N., et al. (2021) · Materials · doi:10.3390/ma14226808 · Cited by 30 · see citing works
Kendall, A. C., Pilkington, S. M., Wray, J. R., Newton, V. L., Griffiths, C. E. M., Bell, M., Watson, R. E. B., & Nicolaou, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-26095-0 · Cited by 31 · see citing works
Alterations of Ultra Long-Chain Fatty Acids in Hereditary Skin Diseases—Review Article
Zwara, A., Wertheim‐Tysarowska, K., & Mika, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.730855 · Cited by 27 · see citing works
Klebeko, J., Ossowicz-Rupniewska, P. E., Nowak, A., Janus, E., Duchnik, W., Adamiak-Giera, U., Kucharski, Ł., Prowans, P., Petriczko, J., Czapla, N., et al. (2021) · Materials · doi:10.3390/ma14216678 · Cited by 26 · see citing works
Takahashi, T., Mercan, S., Sassa, T., Akçapınar, G. B., Yararbaş, K., Süsgün, S., İşerı̇, S. A. U., Kihara, A., & Akçakaya, N. H. (2022) · Brain and Development · doi:10.1016/j.braindev.2022.03.003 · Cited by 25 · see citing works
Self-citationMultiscale Simulation of Ternary Stratum Corneum Lipid Mixtures: Effects of Cholesterol Composition
Shamaprasad, P., Moore, T. C., Xia, D., Iacovella, C. R., Bunge, A. L., & McCabe, C. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c00471 · Cited by 24 · see citing works
Barrier Integrity and Immunity: Exploring the Cutaneous Front Line in Health and Disease
Fukuda, K., Ito, Y., & Amagai, M. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082323-030832 · Cited by 26 · see citing works
Shin, K., Mihara, H., Ishida, K., Uchida, Y., & Park, K. (2022) · Cells · doi:10.3390/cells11111742 · Cited by 22 · see citing works
Lim, S. H., Kim, E. J., Lee, C. H., Park, G. H., Yoo, K. M., Nam, S. J., Shin, K., Park, K., & Choi, E. H. (2021) · Skin Pharmacology and Physiology · doi:10.1159/000518517 · Cited by 21 · see citing works
Nădăban, A., Gooris, G. S., Beddoes, C. M., Dalgliesh, R. M., & Bouwstra, J. A. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100258 · Cited by 21 · see citing works
Ota, A., Morita, H., Naganuma, T., Miyamoto, M., Jojima, K., Nojiri, K., Matsuda, J., & Kihara, A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104603 · Cited by 20 · see citing works
Self-citationRevealing the Correlation between Altered Skin Lipids Composition and Skin Disorders
Drakou, K., Tsianni, A., Vrani, F., Kefala, V., & Rallis, E. A. (2021) · Cosmetics · doi:10.3390/cosmetics8030088 · Cited by 21 · see citing works
Skin Surface Sebum Analysis by ESI-MS
Isom, M., & Desaire, H. (2024) · Biomolecules · doi:10.3390/biom14070790 · Cited by 19 · see citing works
Nowak, A., Duchnik, W., Makuch, E., Kucharski, Ł., Ossowicz-Rupniewska, P. E., Cybulska, K., Sulikowski, T., Moritz, M., & Klimowicz, A. (2021) · Molecules · doi:10.3390/molecules26237188 · Cited by 19 · see citing works
Yamamoto, M., Sassa, T., Kyono, Y., Uemura, H., Kugo, M., Hayashi, H., Imai, Y., Yamanishi, K., & Kihara, A. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15725 · Cited by 18 · see citing works
Self-citationXie, Z., Xie, T., Liu, J. Y., Zhang, Q., & Xiao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054315 · Cited by 17 · see citing works
Methodological Considerations for Lipid and Polar Component Analyses in Human Skin Stratum Corneum
Berdyshev, E. V., Bronova, I. A., Leung, D. Y. M., & Goleva, E. (2021) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-021-01016-6 · Cited by 17 · see citing works
Rousel, J., Mergen, C., Bergmans, M., Klarenbeek, N. B., der Kolk, T. N., van Doorn, M. B. A., Bouwstra, J. A., & Rißmann, R. (2024) · Experimental Dermatology · doi:10.1111/exd.15185 · Cited by 18 · see citing works
Models of the Three-Component Bilayer of Stratum Corneum: A Molecular Simulation Study
Jiang, Z., Liu, S., Yuan, S., Zhang, H., & Yuan, S. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c08461 · Cited by 16 · see citing works
Akiyama, F., Takahashi, N., Ueda, Y., Tada, S., Takeuchi, N., Ohno, Y., & Kihara, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158291 · Cited by 18 · see citing works
Self-citationTomonaga, N., Manabe, Y., Aida, K., & Sugawara, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-70888-0 · Cited by 16 · see citing works
Shen, X., Feng, R., Zhou, R., Zhang, Z., Liu, K., & Wang, S. (2025) · Metabolites · doi:10.3390/metabo15030195 · Cited by 16 · see citing works
Distribution of Domains Formed by Lateral Packing of Intercellular Lipid in the Stratum Corneum
Ohnari, H., Naru, E., Sakata, O., & Obata, Y. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00533 · Cited by 15 · see citing works
Role of Omega-Hydroxy Ceramides in Epidermis: Biosynthesis, Barrier Integrity and Analyzing Method
Ge, F., Sun, K., Hu, Z., & Dong, X. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055035 · Cited by 14 · see citing works
Medicinal Anti-Inflammatory Patch Loaded with Lavender Essential Oil
Zyburtowicz-Ćwiartka, K., Bednarczyk, P., Nowak, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116171 · Cited by 14 · see citing works
Dietary lipids are largely deposited in skin and rapidly affect insulating properties
Riley, N., Kasza, I., Hermsmeyer, I. D. K., Trautman, M. E., Barrett-Wilt, G., Jain, R., Simcox, J., Yen, C. E., MacDougald, O. A., Lamming, D. W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59869-x · Cited by 13 · see citing works
Nădăban, A., Frame, C. O., Yachioui, D. E., Gooris, G. S., Dalgliesh, R. M., Malfois, M., Iacovella, C. R., Bunge, A. L., McCabe, C., & Bouwstra, J. A. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c00554 · Cited by 13 · see citing works
Dietary Ceramide Prepared from Soy Sauce Lees Improves Skin Barrier Function in Hairless Mice
Ohta, K., Hiraki, S., Miyanabe, M., Ueki, T., Manabe, Y., & Sugawara, T. (2021) · Journal of Oleo Science · doi:10.5650/jos.ess21128 · Cited by 13 · see citing works
Adamiak-Giera, U., Nowak, A., Duchnik, W., Ossowicz-Rupniewska, P. E., Czerkawska, A., Machoy‐Mokrzyńska, A., Sulikowski, T., Kucharski, Ł., Białecka, M., Klimowicz, A., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1157977 · Cited by 13 · see citing works
Takagi, Y. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061749 · Cited by 13 · see citing works
Reuter, M., Joseph, E., Lian, G., & Lunter, D. J. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00580 · Cited by 12 · see citing works
Masuda‐Kuroki, K., Alimohammadi, S., & Nardo, A. D. (2023) · Cells · doi:10.3390/cells12192352 · Cited by 12 · see citing works
Rousel, J., Mergen, C., Bergmans, M., Bruijnincx, L. J., de Kam, M. L., Klarenbeek, N. B., der Kolk, T. N., van Doorn, M. B. A., Bouwstra, J. A., & Rißmann, R. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100591 · Cited by 13 · see citing works
Impact of enniatins and beauvericin on lipid metabolism: Insights from a 3D HepaRG spheroid model
Wang, Q., Li, Y., Hu, P., Zhang, Y., Liu, Y., Yang, Q., Xu, L. S., Gong, Z., Yang, J., Sun, W., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108969 · Cited by 12 · see citing works
Preventive effects of dietary fucoxanthin on ultraviolet A induced photoaging in hairless mice
Liu, S., Mohri, S., Tsukamoto, M., Yanai, Y., Manabe, Y., & Sugawara, T. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13842 · Cited by 13 · see citing works
Current Insights on Lipidomics in Dermatology: A Systematic Review
la Torre, R. S.-D., Montero‐Vílchez, T., García‐Gavín, J., & Arias‐Santiago, S. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.09.003 · Cited by 12 · see citing works
Lee, J., Jeon, S., Han, S., Liu, K., Cho, Y., & Kim, K. (2022) · Metabolites · doi:10.3390/metabo13010031 · Cited by 12 · see citing works
Ceramide profiling of stratum corneum in Sjögren–Larsson syndrome
Arai, A., Takeichi, T., Wakamoto, H., Sassa, T., Ito, Y., Murase, Y., Ogi, T., Akiyama, M., & Kihara, A. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.08.003 · Cited by 12 · see citing works
Self-citationZhao, N., Hao, J., Zhao, Y., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020254 · Cited by 11 · see citing works
Rousel, J., Mergen, C., Schoones, J. W., der Kolk, T. N., van Doorn, M. B. A., Bouwstra, J. A., van Smeden, J., & Rißmann, R. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.02.010 · Cited by 11 · see citing works
Considering Phytosphingosine-Based Ceramide Formulations for Atopic Skin Care
Mijaljica, D., Townley, J. P., Hondros, A., Hewson, C., Harrison, I. P., & Spada, F. (2024) · Dermato · doi:10.3390/dermato4010002 · Cited by 11 · see citing works
Role of 2-hydroxy acyl-CoA lyase HACL2 in odd-chain fatty acid production via α-oxidation in vivo
Mori, K., Naganuma, T., & Kihara, A. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-02-0042 · Cited by 9 · see citing works
Self-citationRawlings, A. V., Lane, M. E., & Voegeli, R. (2024) · International Journal of Cosmetic Science · doi:10.1111/ics.12955 · Cited by 10 · see citing works
Filon, F. L., Maculan, P., Crivellaro, M., et al. (2023) · Dermatitis · doi:10.1089/derm.2022.29002.flf · Cited by 9 · see citing works
Emulsion-Based Gel Loaded with Ibuprofen and Its Derivatives
Agboola, A. A., Nowak, A., Duchnik, W., et al. (2023) · Gels · doi:10.3390/gels9050391 · Cited by 9 · see citing works
The phase behavior of skin-barrier lipids: A combined approach of experiments and simulations
Shamaprasad, P., Nădăban, A., Iacovella, C. R., Gooris, G. S., Bunge, A. L., Bouwstra, J. A., & McCabe, C. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2024.07.018 · Cited by 8 · see citing works
Iino, Y., Naganuma, T., & Arita, M. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100329 · Cited by 8 · see citing works
Evaluation of a Novel Skin Emollient Cream on Skin Lipidome and Lipid Organization
Jacques, C., Dejean, C., Klose, C. D., Leccia, E., Bessou‐Touya, S., Delarue, A., & Duplan, H. (2023) · Skin Pharmacology and Physiology · doi:10.1159/000529253 · Cited by 8 · see citing works
Rabionet, M., Bernard, P., Pichery, M., Marsching, C., Bayerle, A., Dworski, S., Kamani, M. A., Chitraju, C., Gluchowski, N. L., Gabriel, K. R., et al. (2022) · Lipids · doi:10.1002/lipd.12342 · Cited by 8 · see citing works
Miyasaka, K., Manse, Y., Yoneda, A., et al. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14353 · Cited by 8 · see citing works
Takeichi, T., Ohno, Y., Tanahashi, K., Ito, Y., Shiraishi, K., Utsunomiya, R., Yoshida, S., Ikeda, K., Nomura, H., Morizane, S., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100308 · Cited by 8 · see citing works
Self-citationAltun, D., Larsson, P., Bergström, C. A. S., et al. (2024) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2024.105448 · Cited by 7 · see citing works
Zhang, Y., Liu, C., Dongxiao, E., et al. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100849 · Cited by 7 · see citing works
Yamamoto, Y., Sassa, T., & Kihara, A. (2023) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2023.12.003 · Cited by 7 · see citing works
Self-citationXi, Y., Long, X., Song, M., et al. (2024) · mBio · doi:10.1128/mbio.02015-23 · Cited by 7 · see citing works
Maiellaro, M., Bottillo, G., Cavallo, A., & Camera, E. (2024) · Scientific Reports · doi:10.1038/s41598-023-50051-1 · Cited by 7 · see citing works
Impaired production of the skin barrier lipid acylceramide by CYP4F22 ichthyosis mutations
Nohara, T., Ohno, Y., & Kihara, A. (2020) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2020.10.003 · Cited by 7 · see citing works
Self-citationNojiri, K., Fudetani, S., Arai, A., Kitamura, T., Sassa, T., & Kihara, A. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00352-21 · Cited by 7 · see citing works
Self-citationInvolvement of ω-O-acylceramides and protein-bound ceramides in oral permeability barrier formation
Sassa, T., & Kihara, A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112363 · Cited by 6 · see citing works
Self-citationPiao, H., Xie, W., Li, S., et al. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02681-x · Cited by 6 · see citing works
Xu, R., Liu, H., Yuan, F., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04419 · Cited by 6 · see citing works
Uchino, T., Hatta, I., Nakajo, M., et al. (2024) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2024.105435 · Cited by 6 · see citing works
Solving the enigma: Mass spectrometry and small molecule probes to study sphingolipid function
Millner, A., & Atilla‐Gokcumen, G. E. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.05.001 · Cited by 6 · see citing works
Pathogenic and Compensatory Mechanisms in Epidermis of Sphingomyelin Synthase 2-Deficient Mice
Sakai, S., Makino, A., Nishi, A., et al. (2021) · Skin Pharmacology and Physiology · doi:10.1159/000515608 · Cited by 6 · see citing works
Shin, S. H., & Moon, M. H. (2024) · Talanta · doi:10.1016/j.talanta.2024.126952 · Cited by 5 · see citing works
Hiranuma, T., Sassa, T., & Kihara, A. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-12-0551 · Cited by 5 · see citing works
Self-citationLipidome Complexity in Physiological and Pathological Skin Pigmentation
Bastonini, E., Kovacs, D., Maresca, V., Ottaviani, M., Nardo, A. D., Flori, E., Cardinali, G., & Briganti, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146785 · Cited by 5 · see citing works
Yamaji, M., Ohno, Y., Shimada, M., & Kihara, A. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100550 · Cited by 5 · see citing works
Self-citationChen, H., Chen, Y., Zhou, Y., Cao, S., Lü, J., Han, L., Worzfeld, T., Krutmann, J., Wang, J., & Xia, J. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.08.027 · Cited by 6 · see citing works
A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS
Ge, K., Zheng, D., Wang, J., Jia, W. P., & Zhao, A. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2022.114982 · Cited by 5 · see citing works
The effect of PPAR isoform (de)activation on the lipid composition in full‐thickness skin models
Helder, R. W. J., Rousel, J., Boiten, W. A., Gooris, G. S., Nădăban, A., Ghalbzouri, A. E., & Bouwstra, J. A. (2022) · Experimental Dermatology · doi:10.1111/exd.14733 · Cited by 4 · see citing works
Tanjung, C., Harris, C. P., Demmelmair, H., Dwitya, S., Munasir, Z., Sudoyo, H., Standl, M., Sjarif, D. R., & Koletzko, B. V. (2022) · Nutrients · doi:10.3390/nu14214676 · Cited by 4 · see citing works
Alqam, M. L., Jones, B. C., & Hitchcock, T. M. (2023) · PubMed Central · Cited by 3 · see citing works
Efficient lipase-catalyzed synthesis of ceramide III series compounds in an eco-friendly solvent
Zhang, X., Ma, Y., OuYang, B., Wang, Y., & Wang, F. (2024) · Molecular Catalysis · doi:10.1016/j.mcat.2024.114006 · Cited by 3 · see citing works
Nădăban, A., Gooris, G. S., Beddoes, C. M., Dalgliesh, R. M., Malfois, M., Demé, B., & Bouwstra, J. A. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184324 · Cited by 3 · see citing works
Reuter, M., Schoenfelder, H., Gaiser, A., Volc, S., & Lunter, D. J. (2025) · Skin Pharmacology and Physiology · doi:10.1159/000545234 · Cited by 3 · see citing works
Mika, A., Pakiet, A., Szczygielski, O., Woźniak, K., Osipowicz, K., Kowaléwski, C., Krześniak, N. E., Noszczyk, B. H., & Wertheim‐Tysarowska, K. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_6131 · Cited by 3 · see citing works
Teo, V. X., Bi, R., Lee, S. H., Chan, J. C. Y., Thng, S. T. G., Olivo, M., & Dinish, U. S. (2025) · Journal of Biophotonics · doi:10.1002/jbio.202400423 · Cited by 2 · see citing works
Dina, D. O., Maiellaro, M., Camera, E., & Connelly, J. T. (2025) · JID Innovations · doi:10.1016/j.xjidi.2025.100383 · Cited by 2 · see citing works
Brezesinski, G., Opálka, L., Shen, C. C., Groetzsch, C., Schneck, E., & Eichner, A. (2025) · Langmuir · doi:10.1021/acs.langmuir.5c01340 · Cited by 2 · see citing works
- Authors
- Kawana, M., Miyamoto, M., Ohno, Y., & Kihara, A.
- Affiliations
- Hokkaido University (JP)
- Corresponding author
- Ohno, Yusuke
- Kihara, Akio
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 61
- Issue
- 6
- Pages
- 884-895
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC7269764
- OpenAlex
- W3015053316
- Semantic Scholar
- d636fe0987fbf6e6a53d593f9c3e15494bebdae9
- Cited by
- 129
- References
- 57
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 31 · 2023: 23 · 2022: 17 · 2021: 19 · 2020: 2
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
- PubMed Central (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University) (submittedVersion, cc-by)
- Funders
- Japan Agency for Medical Research and Development (JP18H03976, JP15H05589)
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- ceramide, stratum corneum, skin barrier function, human-mouse comparison, phytosphingosine, fatty acid elongation, HAP1 cells
- MeSH terms
- Lipidomics, Animals, Ceramides, Chromatography, Liquid, Epidermis, Humans, Mice, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review